BPC-157
Typical Dosage
Injection: 250-500 mcg/day
Oral: 200-1000 mcg/day
Administration
Injection • Oral
Half-Life
4-6 hours
Mechanism of Action
Gastrointestinal repair models|Tendon/ligament healing|Angiogenesis and nitric-oxide signaling|Inflammation modulation
Research Protocol Summary
Evidence Level
Clinical Use / Mixed Literature
Typical Protocol Duration
4-12 weeks
Species Studied
Human • Mouse • Rat
Administration Schedule
Daily
Studies
Research Availability
Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.
Related resources
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Loading approved insights…